TABLE 2.
Univariate and multivariate analysis of factors for prognosis of bladder cancer patients treated with platinum‐based chemotherapy (n = 50)
| Patient characteristic | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| Sex | Male | 1.000 | 1.000 | ||
| Female | 0.300 (0.069‐1.303) | .108 | 0.788 (0.163‐3.796) | .767 | |
| Age, y | ≤70 | 1.000 | 1.000 | ||
| >70 | 1.119 (0.454‐2.758) | .806 | 2.475 (0.863‐7.100) | .092 | |
| Cellular atypism classification | Low grade | 1.000 | 1.000 | ||
| High grade | 0.852 (0.248‐2.931) | .799 | 0.885 (0.208‐3.762) | .868 | |
| Clinical TNM stage | Stage II/III | 1.000 | 1.000 | ||
| Stage IV | 4.099 (1.351‐12.433) | .013 | 7.597 (1.913‐30.166) | .004 | |
| Visceral metastasis | Negative | 1.000 | 1.000 | ||
| Positive | 1.160 (0.337‐3.992) | .813 | 0.546 (0.131‐2.275) | .406 | |
| SLFN11 expression | Negative | 1.000 | 1.000 | ||
| Positive | 0.291 (0.104‐0.811) | .018 | 0.275 (0.094‐0.805) | .018 | |
Abbreviations: CI, confidence interval; OR, odds ratio; SLFN11, Schlafen 11.The significance of bold values are P values less than 0.05